All News #Library
Rare Diseases
Spinogenix Secures FRAXA Backing For Phase 2B (FXS) Trial
02 Mar 2026 //
PR NEWSWIRE
Spinogenix Holds Successful FDA Type C Meeting for SPG601
02 Sep 2025 //
PR NEWSWIRE
Spinogenix`s Spg601 Granted Orphan Drug Status for Fragile X
07 Jul 2025 //
PR NEWSWIRE
Spinogenix`s SPG302 for ALS Gets EMA Orphan Drug Designation
03 Jun 2025 //
PR NEWSWIRE
Spinogenix`s SPG601 Granted FDA Orphan Drug For Fragile X
20 May 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support